Authors
Latest:
Patient-Reported Outcomes Demonstrate Satisfaction With Pembrolizumab in Advanced Cervical CancerData collected with patient-reported outcomes show that pembrolizumab, with or without bevacizumab, is associated with a favorable toxicity profile in effectively treating women with persistent, recurrent, or metastatic cervical cancer.
Latest:
Why We Do What We DoGenevieve's Helping Hands looks to help make the cancer journey easier to navigate, provide an arm to lean on, and offer encouragement when needed.
Latest:
Karen Hagemaster on Chemo Documentation StudyKaren Hagemaster from Advocate Good Samaritan Hospital on Chemotherapy Documentation Study
Latest:
One Million and Counting . . . in Support of Bladder Cancer ResearchWhen my late husband John and I started the Bladder Cancer Advocacy Network (BCAN) in 2005, our goal was not only to raise awareness about bladder cancer, but to change the landscape for this disease by funding research to discover new treatments that will save lives.
Latest:
Easing Decision Making Stress When Younger Women Have Breast CancerA diagnosis of breast cancer is difficult at any age but for younger women, treatment decisions can be especially difficult, with implications that include their future childbearing, sexual health, and body image.
Latest:
Susan Mazanec on Activation for Health ManagementSusan R. Mazanec, PhD, RN, AOCN, Research Assistant Professor, Frances Payne Bolton School of Nursing, Case Western Reserve University, discusses a study that examined activation for health management in colorectal cancer patients and their family caregivers during the transition to post-treatment survivorship.
Latest:
A Navigator Helps Patients Weather the StormsOne versatile nurse used creative ways to ensure that displaced patients received their treatments on time.
Latest:
Association of Community Cancer Centers to Honor Seven Cancer Programs with Innovator Awards at 35th National Oncology ConferenceHundreds of oncology professionals will gather in Phoenix, Arizona, to share best practices and creative approaches that address the most pressing issues facing cancer programs in communities around the country.
Latest:
Palliative Care Needed Alongside Aggressive Cancer TreatmentAfter leading a study that patients with acute myeloid leukemia who receive induction chemotherapy are quite distressed, Tom LeBlanc, hematologic malignancy specialist at Duke Cancer Institute, decided more palliative care should be offered alongside treatment for the disease.
Latest:
Susan Hassmiller on "Staying Relevant" as an Oncology NurseSusan Hassmiller, PhD, RN, FAAN, senior advisor for nursing, Robert Wood Johnson Foundation, discusses what it means to
Latest:
Upstage Lung Cancer Raises Awareness of the Changing Face of Lung CancerA dynamic and uplifting evening of live music hosted by WBZ’s Jordan Rich to strike a chord and raise awareness of the changing face of lung cancer.
Latest:
Nurse-Driven Website Empowers Nurses to Improve Patient CareImproving communication, building relationships, coordinating activities among units, and engaging staff members are not only ways to create a more positive working environment, they are critical for maintaining patient safety.
Latest:
Carlton Brown Describes the ONS Social Media EffortsOncology Nursing Society President Carlton Brown Describes the ONS Social Media Efforts
Latest:
Halle Moore On Breast Cancer Survivorship IssuesHalle Moore, MD, medical oncologist, Cleveland Clinic, discusses survivorship issues and symptoms that breast cancer survivors face.
Latest:
Yuhong Dong on the Benefits of Falun Gong for Patients With Terminal CancerYuhong Dong, MD, PhD, clinical researcher at Novartis, discusses the benefits of practicing Falun Gong for patients with terminal cancer.
Latest:
Adam Dicker on How Nurses Help Combat “White Coat Syndrome”Adam Dicker explains the benefit of nurses when communicating with patients, and how they help to combat "white coat syndrome."
Latest:
Today's Nurse Navigator: Educating and Advocating for Cancer PatientsAs both patient advocate and educator, the ONN partners with physicians to help support the cancer patient's journey throughout the course of disease, with the ultimate goal of improving care and outcomes.
Latest:
Genetic Testing May Add Confusion to Treatment DecisionsAs genetic testing becomes increasingly available, there will be a growing gap between the wide availability of testing and the relative importance of results to treatment decisions. In the current environment, there's more promise in precision medicine than practical applications in the exam room.
Latest:
Oncology Nurses on the Frontlines of Immunotherapy CareCancer immunotherapies continue to show promising clinical outcomes, notably long-lasting remission, for an increasing number of malignancies.
Latest:
Expert Discusses the Safety of VemurafenibAt the 2019 Hairy Cell Leukemia Foundation Annual Conference new findings showed promise in the safety of vemurafenib to treat patients with hairy cell leukemia.
Latest:
Novel Agents, Earlier Diagnosis Driving Survival Gains in CLLThe median overall survival for patients with chronic lymphocytic leukemia has more than tripled since the 1970s, primarily due to an ever-expanding armamentarium of novel agents and earlier diagnosis.
Latest:
Donna L. Berry on Decision Support for Men With Prostate CancerDonna L. Berry, PhD, RN, AOCN, FAAN, Director, Phyllis F. Cantor Center for Research in Nursing & Patient Care Services, Dana-Farber Cancer Institute, Associate Professor, Department of Medicine, Harvard Medical School, discusses decision support for men with localized prostate cancer.
Latest:
Jessica Goldberg Discusses the Lessons Learned from Creating a Self-Management Intervention for Cancer PatientsJessica Goldberg, MSN, adult gerontology nurse practitioner, fellow in palliative medicine, Memorial Sloan Kettering Cancer Center, discusses the results of a study in which a cancer self-management intervention was created for patients with breast cancer.
Latest:
SABCS 2010: Obesity Ups Risk of Recurrence for Some Women With HER2-Negative Breast CancerBeing obese at the time operable breast cancer is diagnosed is associated with inferior outcomes in women with estrogen receptor (ER) or progesterone receptor (PR)positive, HER2-negative breast cancer.
Latest:
Clinical Trials Are Key in Identifying, Eliminating Cancer DisparitiesDue to their strict regulations, clinical trials eliminate room for discriminatory practices, and can lend insight to disparities among groups.
Latest:
Michael Mauro Discusses Therapy-Free CML RemissionMichael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
